Almost a year to the day after Roche pulled out a partnership on its underperforming cancer therapy Gavreto, Blueprint Medicines has sold US commercial rights to the drug to Rigel Pharma in a deal ...

KARACHI: The country’s imports of new and used vehicles, along with auto parts for local assembly, are competing closely as consumers show enthusiasm for both used cars and locally manufactured ...

Rigel Pharmaceuticals has seen its consensus analyst price target rise from $38.33 to $45.40, indicating heightened optimism about the company’s financial trajectory. This optimism coincides with a ...

Rigel Pharmaceuticals (RIGL) could be a solid choice for investors given the company's remarkably improving earnings outlook. While the stock has been a strong performer lately, this trend might ...

Eli Lilly has pulled out of the central nervous system (CNS)-focused portion of a $960 million biobucks deal centered on Rigel Pharmaceuticals’ receptor-interacting serine/threonine-protein kinase 1 ...

SOUTH SAN FRANCISCO, Calif. (AP) — SOUTH SAN FRANCISCO, Calif. (AP) — Rigel Pharmaceuticals Inc. (RIGL) on Tuesday reported net income of $27.9 million in its third quarter. On a per-share basis, the ...

The UN General Assembly convenes every September for deliberations on challenges collectively facing humanity. The United Nations General Assembly will mark its 80th edition from Tuesday, September 9, ...

Rigel's Q2 results were outstanding, with revenue nearly doubling and net income surging, driven by strong commercial momentum for TAVALISSE, GAVRETO, and REZLIDHIA. Management raised 2025 guidance, ...

Investing.com - Jefferies raised its price target on Rigel Pharmaceuticals (NASDAQ:RIGL) to $23.00 from $20.45 while maintaining a Hold rating, citing better-than-expected second-quarter product sales ...

Rigel’s IRAK1/4 inhibitor, R289, has shown promising results in a Phase 1b trial for relapsed/refractory lower-risk myelodysplastic syndrome (LR-MDS). The initial data presented at ASH 2024 ...

For the first time on Singapore TV, 23 neurodivergent individuals interview celebrities and well-known personalities on anything—from fears and regrets to inspirations and dreams. Inspired by France’s ...